µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© 7|"gMw/
#SzCd&hI
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© h zh%ML3L
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© c%|18dV
1.Co-stimulators (or co-stimulating molecules) W+'|zhn
2.NK-kB .mse.$TK.^
3.Immunoglobulin superfamily FTihxC?.L
4.antigen-presenting cell (APC) },2mIit(
5.death domain "Zh6j)[o
6.CCR and CXCR %Q}T9%Mtj
7.Lectin (or mitogen) Mpm#a0f
8.Clusters of differentiation, CD) "0lC:Wu]
9.B7 family N*C"+2
10.Cytotoxic T lymphocyte, CTL) u_C/Y[ik
11.IL-15 and IL-15 receptor (IL-15R) P(1bd"Q
12.MHC restriction v\Y362Xv
13.Affinity-chromatography gCMwmanX
14.Cyctosprin A, CsA RaS7IL:e
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) )1KlcF
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© TZT1nj"n
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ;t.LLd
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ =]pcC
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ .,C8ASfh
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 9`/\|t|V
ÃâÒßѧרҵ£º Lh%>>
Ht{
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ "g)@jqq:>
Ïû»¯ÄÚ¿Æ£º 6$}hb|j
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ /
$ 7_*4e
ѪҺ²¡Ñ§×¨Òµ£º ?lh
`>v
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿